ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Evaluating Long Term Outcomes in Kidney Transplant Patients with TruGraf Gene Expression and TRAC Dd-cfdna in the TRULO Study

P. West-Thielke, W. Ally, J. Hickey, L. Stach, J. Fleming, T. Cober, A. Kawano, I. Agboli, C. Miller, J. Holman

Eurofins Transplant Genomics, Framingham, MA

Meeting: 2022 American Transplant Congress

Abstract number: 1582

Keywords: Gene expression, Kidney transplantation, Outcome, Rejection

Topic: Basic Science » Basic Clinical Science » 17 - Biomarkers: Clinical Outcomes

Session Information

Session Name: Biomarkers: Clinical Outcomes

Session Type: Poster Abstract

Date: Tuesday, June 7, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: The aim of this study is to evaluate long term clinical outcomes in kidney transplant patients undergoing non-invasive rejection monitoring with the OmniGraf® biomarker panel (TruGraf® and TRAC™)

*Methods: The TRULO (TruGraf Long-term Clinical Outcomes) study is a prospective, multi-center, observational study evaluating quarterly surveillance and additional testing when rejection is suspected (for cause) with the OmniGraf biomarker panel, which includes both TruGraf® Gene Expression Profile and TRAC™ donor-derived cell free DNA (dd-cfDNA). The TruGraf test is a qualitative, “rule out” assay that confirms if a patient’s peripheral gene expression is similar to a biopsy confirmed phenotype of no rejection (immune quiescence). TRAC™ dd-cfDNA utilizes single nucleotide polymorphisms (SNPs) present in genes of the organ donor compared to the recipient to estimate the fraction of circulating cfDNA originating from donor. Recent data support that utilizing a combination of gene expression and dd-cfDNA may be complementary in aiding the diagnosis of subclinical rejection.

*Results: The TRULO study will collect data over a 2-year study period with 2000 subjects at about 50 US transplant centers. The primary end point is a composite of the occurrence of either biopsy proven acute rejection (on a for cause biopsy) OR a decrease from baseline in eGFR>10ml/min at 2-years post-enrollment. A key secondary endpoint is the evaluation of the clinical utility surveys performed with each set of TruGraf and TRAC results.

*Conclusions: Enrollment is competitive and site recruitment is still in process with Table 1 describing baseline demographics of the 637 enrolled subjects at time of analysis.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

West-Thielke P, Ally W, Hickey J, Stach L, Fleming J, Cober T, Kawano A, Agboli I, Miller C, Holman J. Evaluating Long Term Outcomes in Kidney Transplant Patients with TruGraf Gene Expression and TRAC Dd-cfdna in the TRULO Study [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/evaluating-long-term-outcomes-in-kidney-transplant-patients-with-trugraf-gene-expression-and-trac-dd-cfdna-in-the-trulo-study/. Accessed May 30, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences